Health ❯Medications

GLP-1 Receptor Agonists

Oral Semaglutide Neurological Health Risks Behavioral Health Tirzepatide

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

The pill form of the diabetes drug Rybelsus demonstrates significant cardiovascular benefits in a major clinical trial.

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies